The full health, economic, and social benefits of prospective Strep A vaccination
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The full health, economic, and social benefits of prospective Strep A vaccination
Authors
Keywords
-
Journal
npj Vaccines
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-30
DOI
10.1038/s41541-023-00758-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlates of immunity to Group A Streptococcus: a pathway to vaccine development
- (2023) Hannah Frost et al. npj Vaccines
- Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model
- (2023) Simone Reynolds et al. npj Vaccines
- Modeling the potential health impact of prospective Strep A vaccines
- (2023) Fiona Giannini et al. npj Vaccines
- Global economic burden per episode for multiple diseases caused by group A Streptococcus
- (2023) Jung-Seok Lee et al. npj Vaccines
- The Streptococcus pyogenes vaccine landscape
- (2023) Donald R. Walkinshaw et al. npj Vaccines
- Optimal global spending for group A Streptococcus vaccine research and development
- (2023) Daniel Tortorice et al. npj Vaccines
- The potential global cost-effectiveness of prospective Strep A vaccines and associated implementation efforts
- (2023) Jung-Seok Lee et al. npj Vaccines
- Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study
- (2023) Chaelin Kim et al. BMJ Global Health
- The value of vaccines
- (2022) JP Sevilla CURRENT OPINION IN IMMUNOLOGY
- The Societal Value of Vaccination in the Age of COVID-19
- (2021) David E. Bloom et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Patterns of Antibiotic Nonsusceptibility Among Invasive Group A Streptococcus Infections—United States, 2006–2017
- (2021) Katherine Fay et al. CLINICAL INFECTIOUS DISEASES
- Clinical management and impact of scarlet fever in the modern era: findings from a cross-sectional study of cases in London, 2018–2019
- (2021) Michael Trent Herdman et al. BMJ Open
- Childhood vaccines and antibiotic use in low- and middle-income countries
- (2020) Joseph A. Lewnard et al. NATURE
- The American Heart Association’s Call to Action for Reducing the Global Burden of Rheumatic Heart Disease: A Policy Statement From the American Heart Association
- (2020) Andrea Beaton et al. CIRCULATION
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- (2020) Theo Vos et al. LANCET
- Contemporary Incidence and Prevalence of Rheumatic Fever and Rheumatic Heart Disease in Australia Using Linked Data: The Case for Policy Change
- (2020) Judith M. Katzenellenbogen et al. Journal of the American Heart Association
- The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease
- (2020) Anna P Ralph et al. MEDICAL JOURNAL OF AUSTRALIA
- Antibiotics as Major Disruptors of Gut Microbiota
- (2020) Jaime Ramirez et al. Frontiers in Cellular and Infection Microbiology
- Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study
- (2019) Élodie Pastural et al. VACCINE
- Motivations of women in Uganda living with rheumatic heart disease: A mixed methods study of experiences in stigma, childbearing, anticoagulation, and contraception
- (2018) Andrew Y. Chang et al. PLoS One
- The broad socioeconomic benefits of vaccination
- (2018) David E. Bloom et al. Science Translational Medicine
- Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora
- (2018) Christine Tedijanto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An economic case for a vaccine to prevent group A streptococcus skin infections
- (2018) Jeffrey W. Cannon et al. VACCINE
- Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015
- (2017) David A. Watkins et al. NEW ENGLAND JOURNAL OF MEDICINE
- The complexity and cost of vaccine manufacturing – An overview
- (2017) Stanley Plotkin et al. VACCINE
- Moving beyond traditional valuation of vaccination: Needs and opportunities
- (2017) David E. Bloom et al. VACCINE
- The broader economic impact of vaccination: reviewing and appraising the strength of evidence
- (2015) Mark Jit et al. BMC Medicine
- Disability weights for the Global Burden of Disease 2013 study
- (2015) Joshua A Salomon et al. Lancet Global Health
- Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
- (2014) M. J. Walker et al. CLINICAL MICROBIOLOGY REVIEWS
- The social value of mortality risk reduction: VSL versus the social welfare function approach
- (2014) Matthew D. Adler et al. JOURNAL OF HEALTH ECONOMICS
- Burden and Economic Cost of Group A Streptococcal Pharyngitis
- (2008) E. Pfoh et al. PEDIATRICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started